Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000879306 | SCV001022328 | likely benign | not provided | 2024-11-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000879306 | SCV001815229 | uncertain significance | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes splice predictors and evolutionary conservation, suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |
Natera, |
RCV001274813 | SCV001459304 | uncertain significance | Usher syndrome type 1B | 2020-04-17 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004541774 | SCV004781265 | likely benign | MYO7A-related disorder | 2020-04-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |